Work

Corrigendum to “Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics” [Regul. Toxicol. Pharmacol. (2017) 221–230]

Year: 2017

Type: erratum

Source: Regulatory Toxicology and Pharmacology

DOI: 10.1016/j.yrtph.2017.04.006

Authors: Christina L.Zuch de Zafra, Vito G. Sasseville, Steven Matsumoto, Christian Freichel, Mark Milton, Timothy K. MacLachlan, Cindy Farman, Iona Raymond, Swati Gupta, Ronald Newton, Elke-Astrid Atzpodien, Evan A. Thackaberry

Institutions: Genentech, Allergan (United States), F. Hoffmann-La Roche AG, Novartis Institutes for BioMedical Research

Language: English

Topic: Immunotoxicology and immune responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2606940292

Cites:

Cited by:

Related to: 10